Samphire Neuroscience Raises $2.3M in Pre-seed Funding for Novel Neurotechnology Wearable Targeting PMS & Menstrual Pain
Feb 21, 2024•over 1 year ago
Amount Raised
$2.3 Million
Round Type
seed
LondonBiotechnologyHealth CareInvestors
Rowena IronsideDr Pamela WalkerRussell BuckleyCvx VenturesAyuhSeasideAfterworkFirstpickSosv
Description
Samphire Neuroscience has successfully raised $2.3 million in pre-seed funding for its pioneering neurotechnology wearable, Nettle, designed to manage PMS and menstrual pain. The funding round drew contributions from venture firms experienced in medical devices and women’s health, as well as prominent angel investors.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers